There have been 50 recent insider transactions recorded for Stoke Therapeutics, Inc. (STOK), including 13 buys and 36 sells. Total insider buying was valued at $1.95M and total insider selling at $33.17M.
Notable insiders with recent activity include Ticho Barry, Allan Jonathan, Hoitt Jason. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — STOK
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-04-01 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
1,838 |
$32.66 |
$60.03K |
38,864 |
| 2026-03-20 |
Allan Jonathan |
General Counsel & Corp Sec |
Informative Sell |
601 |
$34.41 |
$20.68K |
19,543 |
| 2026-03-19 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
1,461 |
$29.99 |
$43.82K |
40,702 |
| 2026-03-18 |
Hoitt Jason |
Chief Patient Officer |
Informative Sell |
30 |
$32.85 |
$985.50 |
10,276 |
| 2026-03-18 |
Leggett Thomas |
Chief Financial Officer |
Informative Sell |
37 |
$32.85 |
$1.22K |
10,172 |
| 2026-03-18 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
103 |
$32.85 |
$3.38K |
40,798 |
| 2026-03-18 |
Allan Jonathan |
General Counsel & Corp Sec |
Informative Sell |
72 |
$32.85 |
$2.37K |
28,836 |
| 2026-03-17 |
Hoitt Jason |
Chief Patient Officer |
Informative Sell |
748 |
$33.38 |
$24.96K |
12,207 |
| 2026-03-17 |
Leggett Thomas |
Chief Financial Officer |
Informative Sell |
922 |
$33.38 |
$30.77K |
12,554 |
| 2026-03-17 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
2,587 |
$33.38 |
$86.34K |
47,484 |
| 2026-03-17 |
Allan Jonathan |
General Counsel & Corp Sec |
Informative Sell |
1,791 |
$33.38 |
$59.78K |
33,464 |
| 2026-03-15 |
Kaye Edward M. Md |
Director |
Option Exercise (Sell) |
35,500 |
- |
- |
35,500 |
| 2026-03-15 |
Hoitt Jason |
Chief Patient Officer |
Option Exercise |
10,000 |
- |
- |
13,988 |
| 2026-03-15 |
Leggett Thomas |
Chief Financial Officer |
Option Exercise |
14,750 |
- |
- |
14,750 |
| 2026-03-15 |
Ticho Barry |
Chief Medical Officer |
Option Exercise (Sell) |
13,100 |
- |
- |
13,100 |
| 2026-03-15 |
Allan Jonathan |
General Counsel & Corp Sec |
Option Exercise (Sell) |
7,475 |
- |
- |
7,475 |
| 2026-03-13 |
Levin Arthur A |
Director |
Informative Sell |
605 |
$36.80 |
$22.26K |
4,237 |
| 2026-03-10 |
Tzianabos Arthur |
Interim Executive Chair |
Informative Sell |
4,355 |
$40.00 |
$174.21K |
31,339 |
| 2026-03-10 |
Krainer Adrian R. |
Director |
Informative Sell |
33,243 |
$39.74 |
$1.32M |
283,302 |
| 2026-03-02 |
Krainer Adrian R. |
Director |
Informative Sell |
7,229 |
$39.66 |
$286.72K |
316,545 |
| 2026-02-17 |
Smith Ian F |
Chief Executive Officer |
RSU Award |
129,000 |
- |
- |
129,000 |
| 2026-02-17 |
Hoitt Jason |
Chief Patient Officer |
RSU Award |
48,000 |
- |
- |
48,000 |
| 2026-02-17 |
Leggett Thomas |
Chief Financial Officer |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2026-02-17 |
Ticho Barry |
Chief Medical Officer |
RSU Award |
40,000 |
- |
- |
40,000 |
| 2026-02-17 |
Allan Jonathan |
General Counsel & Corp Sec |
RSU Award |
35,000 |
- |
- |
35,000 |
| 2025-12-31 |
Levin Arthur A |
Director |
Option Exercise (Sell) |
1,211 |
- |
- |
- |
| 2025-12-08 |
Kaye Edward M. Md |
Director |
Informative Sell |
1,331 |
$33.10 |
$44.06K |
49,124 |
| 2025-12-08 |
Allan Jonathan |
General Counsel & Corp Sec |
Informative Sell |
2,678 |
$32.61 |
$87.34K |
11,831 |
| 2025-12-05 |
Kaye Edward M. Md |
Director |
Informative Sell |
500 |
$31.85 |
$15.92K |
62,554 |
| 2025-12-05 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
1,989 |
$31.35 |
$62.35K |
19,798 |
| 2025-12-05 |
Allan Jonathan |
General Counsel & Corp Sec |
Informative Sell |
2,344 |
$31.76 |
$74.44K |
15,809 |
| 2025-12-04 |
Kaye Edward M. Md |
Director |
Informative Sell |
1,231 |
$31.32 |
$38.55K |
71,102 |
| 2025-12-04 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
323 |
$31.32 |
$10.12K |
23,460 |
| 2025-12-04 |
Allan Jonathan |
General Counsel & Corp Sec |
Informative Sell |
194 |
$31.32 |
$6.08K |
24,594 |
| 2025-12-03 |
Kaye Edward M. Md |
Director |
Informative Sell |
651 |
$30.85 |
$20.08K |
51,305 |
| 2025-12-03 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
1,225 |
$30.85 |
$37.79K |
15,156 |
| 2025-12-03 |
Kaye Edward M. Md |
Director |
Option Exercise (Sell) |
26,250 |
- |
- |
- |
| 2025-12-03 |
Ticho Barry |
Chief Medical Officer |
Option Exercise (Sell) |
10,000 |
- |
- |
- |
| 2025-12-03 |
Allan Jonathan |
General Counsel & Corp Sec |
Option Exercise (Sell) |
6,000 |
- |
- |
- |
| 2025-12-02 |
Kaye Edward M. Md |
Director |
Informative Sell |
405 |
$30.14 |
$12.21K |
52,375 |
| 2025-12-02 |
Ticho Barry |
Chief Medical Officer |
Informative Sell |
762 |
$30.14 |
$22.97K |
17,170 |
| 2025-12-01 |
Ticho Barry |
Chief Medical Officer |
Option Exercise (Sell) |
11,981 |
- |
- |
- |
| 2025-06-18 |
Hoitt Jason |
Chief Patient Officer |
Unknown |
40,000 |
- |
- |
- |
| 2025-06-04 |
Skorpios Trust |
10 Percent Owner |
Informative Sell |
3,000,000 |
$10.20 |
$30.6M |
3,906,181 |
| 2025-06-03 |
Levin Arthur A |
Director |
RSU Award |
29,747 |
$10.90 |
$324.24K |
29,747 |
| 2025-06-03 |
Harrison Seth Loring |
Director |
RSU Award |
29,747 |
$10.90 |
$324.24K |
29,747 |
| 2025-06-03 |
Menzel Garry E |
Director |
RSU Award |
29,747 |
$10.90 |
$324.24K |
29,747 |
| 2025-06-03 |
Smith Julie |
Director |
RSU Award |
29,747 |
$10.90 |
$324.24K |
29,747 |
| 2025-06-03 |
Burstein Jennifer |
Director |
RSU Award |
29,747 |
$10.90 |
$324.24K |
29,747 |
| 2025-06-03 |
Krainer Adrian R. |
Director |
RSU Award |
29,747 |
$10.90 |
$324.24K |
29,747 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
